Literature DB >> 53042

Blood viscosity, plasma proteins, and Raynaud syndrome.

G W Tietjen, S Chien, E C Leroy, I Gavras, H Gavras, F E Gump.   

Abstract

The rheology of the blood was studied in 20 patients with Raynaud syndrome. Sixteen patients had scleroderma, two had nonspecific angiitis, one had systemic lupus erythematosus, and one had Raynaud disease. Viscosity measurements were performed on whole blood, plasma, and suspensions of 45% red blood cells (RBCs). In autologous plasma, over a wide range of shear rates. The relative viscosity, an index of RBC aggregation, was obtained by dividing the RBC viscosity in autologous plasma (at a hematocrit value of 45%) by the plasma viscosity. Concentrations of the plasma globulins and fibrinogen were also measured. The mean plasma viscosity was significantly (P less than .01) elevated over established normal controls. The mean RBC viscosity and the relative viscosity were significantly (P less than .01) elevated over normal controls, as were fibrinogen and the globulins. These studies demonstrate increased blood viscosity and red blood cell aggregation, which may constitute an important hindrance to flow.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 53042     DOI: 10.1001/archsurg.1975.01360170083011

Source DB:  PubMed          Journal:  Arch Surg        ISSN: 0004-0010


  7 in total

1.  Whole blood viscosity in systemic sclerosis: a potential biomarker of pulmonary hypertension?

Authors:  Bihter Senturk; Bahri Akdeniz; Mehmet Birhan Yilmaz; Buse Ozcan Kahraman; Burak Acar; Sadettin Uslu; Merih Birlik
Journal:  Clin Rheumatol       Date:  2019-05-26       Impact factor: 2.980

2.  Optical coherence tomography for evaluating capillary waves in blood and plasma.

Authors:  Hsiao-Chuan Liu; Piotr Kijanka; Matthew W Urban
Journal:  Biomed Opt Express       Date:  2020-01-24       Impact factor: 3.732

Review 3.  Blood rheology.

Authors:  J Stuart; M W Kenny
Journal:  J Clin Pathol       Date:  1980-05       Impact factor: 3.411

4.  Assessment of platelet function in patients with Raynaud's syndrome.

Authors:  R A Hutton; D P Mikhailidis; R M Bernstein; J Y Jeremy; G R Hughes; P Dandona
Journal:  J Clin Pathol       Date:  1984-02       Impact factor: 3.411

5.  Treatment of vasospastic disease with prostaglandin E1.

Authors:  P C Clifford; M F Martin; E J Sheddon; J D Kirby; R N Baird; P A Dieppe
Journal:  Br Med J       Date:  1980-10-18

Review 6.  Therapeutic plasma exchange for the treatment of systemic sclerosis: A comprehensive review and analysis.

Authors:  Edward S Harris; Herbert J Meiselman; Patrick M Moriarty; Allan Metzger; Miroslav Malkovsky
Journal:  J Scleroderma Relat Disord       Date:  2018-03-09

7.  Unfavourably altered plasma clot properties in patients with primary Raynaud's phenomenon: association with venous thromboembolism.

Authors:  Joanna Żuk; Agnieszka Snarska-Drygalska; Krzysztof Piotr Malinowski; Elżbieta Papuga-Szela; Joanna Natorska; Anetta Undas
Journal:  J Thromb Thrombolysis       Date:  2019-02       Impact factor: 2.300

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.